Critical path in cardiac stem cell therapy: An update on cell delivery

Cytotherapy

Volumn 15, Issue 4, 2013, Pages 399-415

  Shim, Winston ^a   Mehta, Ashish ^a   Wong, Philip ^a   Chua, Terrance ^a   Koh, Tian Hai ^a  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

cardiac repair; cell delivery; intra coronary; intra myocardial; myocardial infarction; stem cell therapy

Indexed keywords

HEMATOPOIETIC STEM CELL; HUMAN; INJECTION; INTERMETHOD COMPARISON; INTRACORONARY INFUSION; MESENCHYMAL STEM CELL; MESOTHELIUM CELL; MONONUCLEAR CELL; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REPAIR;

ADMINISTRATION, INTRAVENOUS; CARDIOMYOPATHIES; HEART; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84875714365     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2012.11.003     Document Type: Review

References (145)

1. S. Charwat, M. Gyongyosi, I. Lang, S. Graf, G. Beran, and R. Hemetsberger Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art Exp Hematol 36 2008 672 680
2. H. Wei, T.H. Ooi, G. Tan, S.Y. Lim, L. Qian, and P. Wong Cell delivery and tracking in post-myocardial infarction cardiac stem cell therapy: an introduction for clinical researchers Heart Fail Rev 15 2010 1 14
3. D. Orlic, J. Kajstura, S. Chimenti, F. Limana, I. Jakoniuk, and F. Quaini Mobilized bone marrow cells repair the infarcted heart, improving function and survival Proc Natl Acad Sci U S A 98 2001 10344 10349
4. B. Assmus, V. Schachinger, C. Teupe, M. Britten, R. Lehmann, and N. Dobert Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) Circulation 106 2002 3009 3017
5. B.E. Strauer, M. Brehm, T. Zeus, M. Kostering, A. Hernandez, and R.V. Sorg Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 2002 1913 1918
6. C. Stamm, B. Westphal, H.D. Kleine, M. Petzsch, C. Kittner, and H. Klinge Autologous bone-marrow stem-cell transplantation for myocardial regeneration Lancet 361 2003 45 46
7. K.C. Wollert, G.P. Meyer, J. Lotz, S. Ringes-Lichtenberg, P. Lippolt, and C. Breidenbach Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial Lancet 364 2004 141 148
8. V. Schachinger, S. Erbs, A. Elsasser, W. Haberbosch, R. Hambrecht, and H. Holschermann Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial Eur Heart J 27 2006 2775 2783
9. K. Lunde, S. Solheim, S. Aakhus, H. Arnesen, M. Abdelnoor, and K. Forfang Autologous stem cell transplantation in acute myocardial infarction: the ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects Scand Cardiovasc J 39 2005 150 158
10. S. Janssens, C. Dubois, J. Bogaert, K. Theunissen, C. Deroose, and W. Desmet Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial Lancet 367 2006 113 121
11. G. Condorelli, U. Borello, L. De Angelis, M. Latronico, D. Sirabella, and M. Coletta Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration Proc Natl Acad Sci U S A 98 2001 10733 10738
12. A.A. Mangi, N. Noiseux, D. Kong, H. He, M. Rezvani, and J.S. Ingwall Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts Nat Med 9 2003 1195 1201
13. J.M. Nygren, S. Jovinge, M. Breitbach, P. Sawen, W. Roll, and J. Hescheler Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation Nat Med 10 2004 494 501
14. A. Leri, J. Kajstura, and P. Anversa Cardiac stem cells and mechanisms of myocardial regeneration Physiol Rev 85 2005 1373 1416
15. A.I. Caplan, and J.E. Dennis Mesenchymal stem cells as trophic mediators J Cell Biochem 98 2006 1076 1084
16. M. Gnecchi, H. He, N. Noiseux, O.D. Liang, L. Zhang, and F. Morello Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement FASEB J 20 2006 661 669
17. H. Reinecke, V. Poppa, and C.E. Murry Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting J Mol Cell Cardiol 34 2002 241 249
18. P. Menasche, A.A. Hagege, J.T. Vilquin, M. Desnos, E. Abergel, and B. Pouzet Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction J Am Coll Cardiol 41 2003 1078 1083
19. S. Shintani, T. Murohara, H. Ikeda, T. Ueno, T. Honma, and A. Katoh Mobilization of endothelial progenitor cells in patients with acute myocardial infarction Circulation 103 2001 2776 2779
20. A.M. Leone, S. Rutella, G. Bonanno, A. Abbate, A.G. Rebuzzi, and S. Giovannini Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function Eur Heart J 26 2005 1196 1204
21. H.J. Kang, H.S. Kim, S.Y. Zhang, K.W. Park, H.J. Cho, and B.K. Koo Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial Lancet 363 2004 751 756
22. P.J. Psaltis, A.C. Zannettino, S.G. Worthley, and S. Gronthos Concise review: mesenchymal stromal cells: potential for cardiovascular repair Stem Cells 26 2008 2201 2210
23. J.M. Hare, J.H. Traverse, T.D. Henry, N. Dib, R.K. Strumpf, and S.P. Schulman A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction J Am Coll Cardiol 54 2009 2277 2286
24. J.C. Kovacic, D.W. Muller, and R.M. Graham Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease J Mol Cell Cardiol 42 2007 19 33
25. W. Shim, A. Mehta, S.Y. Lim, G. Zhang, C.H. Lim, and T. Chua G-CSF for stem cell therapy in acute myocardial infarction: friend or foe? Cardiovasc Res 89 2011 20 30
26. I.M. Barbash, P. Chouraqui, J. Baron, M.S. Feinberg, S. Etzion, and A. Tessone Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution Circulation 108 2003 863 868
27. D.L. Kraitchman, M. Tatsumi, W.D. Gilson, T. Ishimori, D. Kedziorek, and P. Walczak Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction Circulation 112 2005 1451 1461
28. J. Ma, J. Ge, S. Zhang, A. Sun, J. Shen, and L. Chen Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction Basic Res Cardiol 100 2005 217 223
29. T. Freyman, G. Polin, H. Osman, J. Crary, M. Lu, and L. Cheng A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction Eur Heart J 27 2006 1114 1122
30. F.B. Nogueira, S.A. Silva, A.F. Haddad, C.M. Peixoto, R.M. Carvalho, and F.A. Tuche Systolic function of patients with myocardial infarction undergoing autologous bone marrow transplantation Arq Bras Cardiol 93 2009 374 379 367-72
31. E.C. Perin, and J. Lopez Methods of stem cell delivery in cardiac diseases Nat Clin Pract Cardiovasc Med 3 Suppl. 1 2006 S110 S113
32. M. Kurpisz, R. Czepczynski, B. Grygielska, M. Majewski, D. Fiszer, and O. Jerzykowska Bone marrow stem cell imaging after intracoronary administration Int J Cardiol 121 2007 194 195
33. R. Schots, G. De Keulenaer, D. Schoors, V. Caveliers, M. Dujardin, and S. Verheye Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure Exp Hematol 35 2007 1884 1890
34. J. Bartunek, M. Vanderheyden, B. Vandekerckhove, S. Mansour, B. De Bruyne, and P. De Bondt Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety Circulation 112 9 Suppl. 2005 I178 I183
35. B.E. Strauer, M. Brehm, T. Zeus, T. Bartsch, C. Schannwell, and C. Antke Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study J Am Coll Cardiol 46 2005 1651 1658
36. B. Assmus, J. Honold, V. Schachinger, M.B. Britten, U. Fischer-Rasokat, and R. Lehmann Transcoronary transplantation of progenitor cells after myocardial infarction N Engl J Med 355 2006 1222 1232
37. A.J. Boyle, R. Whitbourn, S. Schlicht, H. Krum, A. Kocher, and H. Nandurkar Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up Int J Cardiol 109 2006 21 27
38. S. Seth, R. Narang, B. Bhargava, R. Ray, S. Mohanty, and G. Gulati Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial J Am Coll Cardiol 48 2006 2350 2351
39. J. Meluzin, J. Mayer, L. Groch, S. Janousek, I. Hornacek, and O. Hlinomaz Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function Am Heart J 152 2006 975.e9 975.e15
40. G. Karatasakis, E. Leontiadis, I. Peristeri, A. Manginas, E. Goussetis, and S. Graphakos Intracoronary infusion of selected autologous bone marrow stem cells improves longitudinal myocardial strain and strain rate in patients with old anterior myocardial infarction without recent revascularization Eur J Echocardiogr 11 2010 440 445
41. B. Assmus, A. Rolf, S. Erbs, A. Elsasser, W. Haberbosch, and R. Hambrecht Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction Circ Heart Fail 3 2010 89 96
42. J.A. Miettinen, K. Ylitalo, P. Hedberg, J. Jokelainen, K. Kervinen, and M. Niemela Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy Heart 96 2010 362 367
43. F.H. Seeger, T. Tonn, N. Krzossok, A.M. Zeiher, and S. Dimmeler Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction Eur Heart J 28 2007 766 772
44. S. Dimmeler, J. Burchfield, and A.M. Zeiher Cell-based therapy of myocardial infarction Arterioscler Thromb Vasc Biol 28 2008 208 216
45. R. Flores-Ramirez, A. Uribe-Longoria, M.M. Rangel-Fuentes, P. Gutierrez-Fajardo, R. Salazar-Riojas, and D. Cervantes-Garcia Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency Cardiovasc Revasc Med 11 2010 72 78
46. B.E. Strauer Clinical perspectives of heart muscle regeneration by stem cells: a future-oriented epilogue [Klinische Perspektiven der Herzmuskelregeneration durch Stammzellen: Ein zukunftsorientierter Epilog] Herz 35 2010 474 476 [in German]
47. J.H. Traverse, T.D. Henry, S.G. Ellis, C.J. Pepine, J.T. Willerson, and D.X. Zhao Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial JAMA 306 2011 2110 2119
48. A. Kawamoto, T. Tkebuchava, J. Yamaguchi, H. Nishimura, Y.S. Yoon, and C. Milliken Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia Circulation 107 2003 461 468
49. E.C. Perin, H.F. Dohmann, R. Borojevic, S.A. Silva, A.L. Sousa, and C.T. Mesquita Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure Circulation 107 2003 2294 2302
50. L.C. Amado, A.P. Saliaris, K.H. Schuleri, M. St John, J.S. Xie, and S. Cattaneo Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction Proc Natl Acad Sci U S A 102 2005 11474 11479
51. D. Hou, E.A. Youssef, T.J. Brinton, P. Zhang, P. Rogers, and E.T. Price Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials Circulation 112 9 Suppl. 2005 I150 I156
52. M. Gyongyosi, J. Blanco, T. Marian, L. Tron, O. Petnehazy, and Z. Petrasi Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression Circ Cardiovasc Imaging 1 2008 94 103
53. D.W. Losordo, P.R. Vale, J.F. Symes, C.H. Dunnington, D.D. Esakof, and M. Maysky Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia Circulation 98 1998 2800 2804
54. R.J. Laham, M. Post, M. Rezaee, L. Donnell-Fink, J.J. Wykrzykowska, and S.U. Lee Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distribution Drug Metab Dispos 33 2005 1101 1107
55. R. Waksman, J. Fournadjiev, R. Baffour, R. Pakala, D. Hellinga, and L. Leborgne Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium Cardiovasc Radiat Med 5 2004 125 131
56. E. Leotta, G. Patejunas, G. Murphy, J. Szokol, L. McGregor, and J. Carbray Gene therapy with adenovirus-mediated myocardial transfer of vascular endothelial growth factor 121 improves cardiac performance in a pacing model of congestive heart failure J Thorac Cardiovasc Surg 123 2002 1101 1113
57. R. Kornowski, S. Fuchs, M.B. Leon, and S.E. Epstein Delivery strategies to achieve therapeutic myocardial angiogenesis Circulation 101 2000 454 458
58. N. Dib, H. Khawaja, S. Varner, M. McCarthy, and A. Campbell Cell therapy for cardiovascular disease: a comparison of methods of delivery J Cardiovasc Transl Res 4 2011 177 181
59. P. Menasche, O. Alfieri, S. Janssens, W. McKenna, H. Reichenspurner, and L. Trinquart The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation Circulation 117 2008 1189 1200
60. N. Dib, R.E. Michler, F.D. Pagani, S. Wright, D.J. Kereiakes, and R. Lengerich Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up Circulation 112 2005 1748 1755
61. G. Pompilio, G. Steinhoff, A. Liebold, M. Pesce, F. Alamanni, and M.C. Capogrossi Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results Thorac Cardiovasc Surg 56 2008 71 76
62. N. Dib, P. Menasche, J.J. Bartunek, A.M. Zeiher, A. Terzic, and N.A. Chronos Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research JACC Cardiovasc Interv 3 2010 265 275
63. E.C. Perin, G.V. Silva, R. Sarmento-Leite, W.K. Vaughn, R.D. Fish, and J.J. Ferguson 3rd Left ventricular electromechanical mapping: preliminary evidence of electromechanical changes after successful coronary intervention Am Heart J 144 2002 693 701
64. P.M. Grossman, Z. Han, M. Palasis, J.J. Barry, and R.J. Lederman Incomplete retention after direct myocardial injection Catheter Cardiovasc Interv 55 2002 392 397
65. H. Ince, M. Petzsch, T.C. Rehders, T. Chatterjee, and C.A. Nienaber Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction J Endovasc Ther 11 2004 695 704
66. N. Dib, J. Dinsmore, Z. Lababidi, B. White, S. Moravec, and A. Campbell One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study) JACC Cardiovasc Interv 2 2009 9 16
67. K. Krause, K. Jaquet, C. Schneider, S. Haupt, M.V. Lioznov, and K.M. Otte Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study Heart 95 2009 1145 1152
68. D.W. Losordo, R.A. Schatz, C.J. White, J.E. Udelson, V. Veereshwarayya, and M. Durgin Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial Circulation 115 2007 3165 3172
69. H.M. Klein, A. Ghodsizad, R. Marktanner, L. Poll, T. Voelkel, and M.R. Mohammad Hasani Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery Heart Surg Forum 10 2007 E66 E69
70. K.V. Arom, P. Ruengsakulrach, and V. Jotisakulratana Intramyocardial angiogenic cell precursor injection for cardiomyopathy Asian Cardiovasc Thorac Ann 16 2008 143 148
71. D.W. Losordo, T.D. Henry, C. Davidson, J. Sup Lee, M.A. Costa, and T. Bass Intramyocardial, autologous CD34+ cell therapy for refractory angina Circ Res 109 2011 428 436
72. A.R. Williams, B. Trachtenberg, D.L. Velazquez, I. McNiece, P. Altman, and D. Rouy Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling Circ Res 108 2011 792 796
73. E.C. Perin, J.T. Willerson, C.J. Pepine, T.D. Henry, S.G. Ellis, and D.X. Zhao Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial JAMA 307 2012 1717 1726
74. S. Charwat, I. Lang, M. Dettke, S. Graf, N. Nyolczas, and R. Hemetsberger Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study Thromb Haemost 103 2010 564 571
75. G. Astori, S. Soncin, V. Lo Cicero, F. Siclari, D. Surder, and L. Turchetto Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products Am J Transl Res 2 2010 285 295
76. M. Rota, J. Kajstura, T. Hosoda, C. Bearzi, S. Vitale, and G. Esposito Bone marrow cells adopt the cardiomyogenic fate in vivo Proc Natl Acad Sci U S A 104 2007 17783 17788
77. K.C. Wollert, and H. Drexler Cell therapy for the treatment of coronary heart disease: a critical appraisal Nat Rev Cardiol 7 2010 204 215
78. Y.S. Yoon, N. Lee, and H. Scadova Myocardial regeneration with bone-marrow-derived stem cells Biol Cell 97 2005 253 263
79. R.O. Cannon 3rd, and C.E. Dunbar BM-derived cell therapies for cardiovascular disease Cytotherapy 9 2007 305 315
80. S.J. Brunskill, C.J. Hyde, C.J. Doree, S.M. Watt, and E. Martin-Rendon Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease Eur J Heart Fail 11 2009 887 896
81. Y. Wen, L. Meng, J. Xie, and J. Ouyang Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a meta-analysis Expert Opin Biol Ther 11 2011 559 567
82. P. Donndorf, G. Kundt, A. Kaminski, C. Yerebakan, A. Liebold, and G. Steinhoff Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis J Thorac Cardiovasc Surg 142 2011 911 920
83. M. Jiang, B. He, Q. Zhang, H. Ge, M.H. Zang, and Z.H. Han Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis Expert Opin Biol Ther 10 2010 667 680
84. S. Kang, Y.J. Yang, C.J. Li, and R.L. Gao Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials Coron Artery Dis 19 2008 327 335
85. S.N. Zhang, A.J. Sun, J.B. Ge, K. Yao, Z.Y. Huang, and K.Q. Wang Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials Int J Cardiol 136 2009 178 185
86. L. Sun, T. Zhang, X. Lan, and G. Du Effects of stem cell therapy on left ventricular remodeling after acute myocardial infarction: a meta-analysis Clin Cardiol 33 2010 296 302
87. E. Martin-Rendon, S.J. Brunskill, C.J. Hyde, S.J. Stanworth, A. Mathur, and S.M. Watt Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review Eur Heart J 29 2008 1807 1818
88. R. Sanz-Ruiz, E. Gutierrez Ibanes, A.V. Arranz, M.E. Fernandez Santos, P.L. Fernandez, and F. Fernandez-Aviles Phases I-III clinical trials using adult stem cells Stem Cells Int 2010 2010 579142
89. D. Simpson, H. Liu, T.H. Fan, R. Nerem, and S.C. Dudley Jr. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling Stem Cells 25 2007 2350 2357
90. P.C. Smits, R.J. van Geuns, D. Poldermans, M. Bountioukos, E.E. Onderwater, and C.H. Lee Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up J Am Coll Cardiol 42 2003 2063 2069
91. T. Siminiak, R. Kalawski, D. Fiszer, O. Jerzykowska, J. Rzezniczak, and N. Rozwadowska Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up Am Heart J 148 2004 531 537
92. P. Menasche Stem cell therapy for heart failure: are arrhythmias a real safety concern? Circulation 119 2009 2735 2740
93. K. Fouts, B. Fernandes, N. Mal, J. Liu, and K.R. Laurita Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium Heart Rhythm 3 2006 452 461
94. S. Fukushima, A. Varela-Carver, S.R. Coppen, K. Yamahara, L.E. Felkin, and J. Lee Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model Circulation 115 2007 2254 2261
95. M. Taljaard, M.R. Ward, M.J. Kutryk, D.W. Courtman, N.J. Camack, and S.G. Goodman Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction Am Heart J 159 2010 354 360
96. S. Pasquet, H. Sovalat, P. Henon, N. Bischoff, Y. Arkam, and M. Ojeda-Uribe Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct Cytotherapy 11 2009 1002 1015
97. C. Stamm, H.D. Kleine, Y.H. Choi, S. Dunkelmann, J.A. Lauffs, and B. Lorenzen Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies J Thorac Cardiovasc Surg 133 2007 717 725
98. M.A. Laflamme, K.Y. Chen, A.V. Naumova, V. Muskheli, J.A. Fugate, and S.K. Dupras Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts Nat Biotechnol 25 2007 1015 1024
99. M. Okada, T.R. Payne, B. Zheng, H. Oshima, N. Momoi, and K. Tobita Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium J Am Coll Cardiol 52 2008 1869 1880
100. P.V. Johnston, T. Sasano, K. Mills, R. Evers, S.T. Lee, and R.R. Smith Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy Circulation 120 2009 1075 1083
101. R.R. Makkar, R.R. Smith, K. Cheng, K. Malliaras, L.E. Thomson, and D. Berman Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial Lancet 379 2012 895 904
102. B. Bourahla, A. Shafy, O. Meilhac, I. Elmadbouh, J.B. Michel, and J.C. Chachques Mesothelial cells vs. skeletal myoblasts for myocardial infarction Asian Cardiovasc Thorac Ann 18 2010 153 160
103. X. Bai, Y. Yan, Y.H. Song, M. Seidensticker, B. Rabinovich, and R. Metzele Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction Eur Heart J 31 2010 489 501
104. A.P. Beltrami, L. Barlucchi, D. Torella, M. Baker, F. Limana, and S. Chimenti Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776
105. A. Linke, P. Muller, D. Nurzynska, C. Casarsa, D. Torella, and A. Nascimbene Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function Proc Natl Acad Sci U S A 102 2005 8966 8971
106. C. Bearzi, M. Rota, T. Hosoda, J. Tillmanns, A. Nascimbene, and A. De Angelis Human cardiac stem cells Proc Natl Acad Sci U S A 104 2007 14068 14073
107. J. Roncalli, F. Mouquet, C. Piot, J.N. Trochu, P. Le Corvoisier, and Y. Neuder Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial Eur Heart J 32 2011 1748 1757
108. S.L. Chen, W.W. Fang, J. Qian, F. Ye, Y.H. Liu, and S.J. Shan Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction Chin Med J (Engl) 117 2004 1443 1448
109. A. Hirsch, R. Nijveldt, P.A. van der Vleuten, J.G. Tijssen, W.J. van der Giessen, and R.A. Tio Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial Eur Heart J 32 2011 1736 1747
110. J. Ge, Y. Li, J. Qian, J. Shi, Q. Wang, and Y. Niu Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI) Heart 92 2006 1764 1767
111. W. Ruan, C.Z. Pan, G.Q. Huang, Y.L. Li, J.B. Ge, and X.H. Shu Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging Chin Med J (Engl) 118 2005 1175 1181
112. M. Tendera, W. Wojakowski, W. Ruzyllo, L. Chojnowska, C. Kepka, and W. Tracz Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial Eur Heart J 30 2009 1313 1321
113. E. Straburzynska-Migaj, M. Popiel, S. Grajek, A. Katarzynska-Szymanska, M. Lesiak, and P. Breborowicz Exercise capacity, arrhythmic risk profile, and pulmonary function is not influenced by intracoronary injection of bone marrow stem cells in patients with acute myocardial infarction Int J Cardiol 159 2012 134 138
114. M. Penicka, J. Horak, P. Kobylka, R. Pytlik, T. Kozak, and O. Belohlavek Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study J Am Coll Cardiol 49 2007 2373 2374
115. M. Plewka, M. Krzeminska-Pakula, J.Z. Peruga, P. Lipiec, M. Kurpesa, and K. Wierzbowska-Drabik The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results Kardiol Pol 69 2011 1234 1240
116. J.H. Traverse, D.H. McKenna, K. Harvey, B.C. Jorgenso, R.E. Olson, and N. Bostrom Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction Am Heart J 160 2010 428 434
117. H.J. Kang, H.S. Kim, B.K. Koo, Y.J. Kim, D. Lee, and D.W. Sohn Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial Am Heart J 153 2007 237.e1 237.e8
118. J.O. Beitnes, E. Hopp, K. Lunde, S. Solheim, H. Arnesen, and J.E. Brinchmann Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study Heart 95 2009 1983 1989
119. F. Kuethe, B.M. Richartz, H.G. Sayer, C. Kasper, G.S. Werner, and K. Hoffken Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions Int J Cardiol 97 2004 123 127
120. R. Bolli, A.R. Chugh, D. D'Amario, J.H. Loughran, M.F. Stoddard, and S. Ikram Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial Lancet 378 2011 1847 1857
121. J.C. Kovacic, P. Macdonald, M.P. Feneley, D.W. Muller, J. Freund, and A. Dodds Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial Am Heart J 156 2008 954 963
122. A.C. Diederichsen, J.E. Moller, P. Thayssen, A.B. Junker, L. Videbaek, and S.G. Saekmose Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure: the Danish stem cell study - congestive heart failure trial (DanCell-CHF) Eur J Heart Fail 10 2008 661 667
123. B.E. Strauer, M. Yousef, and C.M. Schannwell The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study Eur J Heart Fail 12 2010 721 729
124. E.A. Bocchi, F. Bacal, G. Guimaraes, A. Mendroni, A. Mocelin, and A.E. Filho Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure Int J Cardiol 138 2010 94 97
125. T. Yelda, U. Berrin, S. Murat, O. Aytac, B. Sevgi, and S. Yasemin Intracoronary stem cell infusion in heart transplant candidates Tohoku J Exp Med 213 2007 113 120
126. D.G. Katritsis, P. Sotiropoulou, E. Giazitzoglou, E. Karvouni, and M. Papamichail Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells Europace 9 2007 167 171
127. A. Manginas, E. Goussetis, M. Koutelou, G. Karatasakis, I. Peristeri, and A. Theodorakos Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction Catheter Cardiovasc Interv 69 2007 773 781
128. S. Seth, B. Bhargava, R. Narang, R. Ray, S. Mohanty, and G. Gulati The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial: a long-term follow-up study J Am Coll Cardiol 55 2010 1643 1644
129. S. Mansour, D.C. Roy, V. Bouchard, B.K. Nguyen, L.M. Stevens, and F. Gobeil COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design J Cardiovasc Transl Res 3 2010 153 159
130. H. Ahmadi, M.M. Farahani, A. Kouhkan, K. Moazzami, R. Fazeli, and H. Sadeghian Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction Arch Iran Med 15 2012 32 35
131. M. Gyongyosi, I. Lang, M. Dettke, G. Beran, S. Graf, and H. Sochor Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study Nat Clin Pract Cardiovasc Med 6 2009 70 81
132. S. Fuchs, L.F. Satler, R. Kornowski, P. Okubagzi, G. Weisz, and R. Baffour Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study J Am Coll Cardiol 41 2003 1721 1724
133. E. Pokushalov, A. Romanov, A. Chernyavsky, P. Larionov, I. Terekhov, and S. Artyomenko Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study J Cardiovasc Transl Res 3 2010 160 168
134. G.V. Silva, E.C. Perin, H.F. Dohmann, R. Borojevic, S.A. Silva, and A.L. Sousa Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation Tex Heart Inst J 31 2004 214 219
135. K. Hamano, M. Nishida, K. Hirata, A. Mikamo, T.S. Li, and M. Harada Local
136. H.F. Tse, Y.L. Kwong, J.K. Chan, G. Lo, C.L. Ho, and C.P. Lau Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation Lancet 361 2003 47 49
137. A. Rivas-Plata, J. Castillo, M. Pariona, and A. Chunga Bypass grafts and cell transplant in heart failure with low ejection fraction Asian Cardiovasc Thorac Ann 18 2010 425 429
138. E.C. Perin, G.V. Silva, T.D. Henry, M.G. Cabreira-Hansen, W.H. Moore, and S.A. Coulter A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF) Am Heart J 161 2011 1078 1087.e3
139. A.N. Patel, L. Geffner, R.F. Vina, J. Saslavsky, H.C. Urschel Jr., and R. Kormos Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study J Thorac Cardiovasc Surg 130 2005 1631 1638
140. K.J. Yoo, H.O. Kim, Y.L. Kwak, S.M. Kang, Y.S. Jang, and S.H. Lim Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy Can J Surg 51 2008 269 275
141. M. Galinanes, M. Loubani, J. Davies, D. Chin, J. Pasi, and P.R. Bell Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans Cell Transplant 13 2004 7 13
142. G. Reyes, K.B. Allen, P. Alvarez, A. Alegre, B. Aguado, and M. Olivera Mid term results after bone marrow laser revascularization for treating refractory angina BMC Cardiovasc Disord 10 2010 42
143. S.L. Beeres, J.J. Bax, P. Dibbets, M.P. Stokkel, K. Zeppenfeld, and W.E. Fibbe Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia J Nucl Med 47 2006 574 580
144. R. Arguero, G. Careaga-Reyna, R. Castano-Guerra, M.H. Garrido-Garduno, J.A. Magana-Serrano, and M. de Jesus Nambo-Lucio Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy: preliminary report Arch Med Res 37 2006 1010 1014
145. A. Archundia, J.L. Aceves, M. Lopez-Hernandez, M. Alvarado, E. Rodriguez, and G. Diaz Quiroz Direct cardiac injection of G-CSF mobilized bone-marrow stem-cells improves ventricular function in old myocardial infarction Life Sci 78 2005 279 283